The Tencent-backed geospatial data technology developer will acquire a Nasdaq listing through the transaction, giving it an $850m implied enterprise value.

Swisscom and Hitachi-backed genomic data technology provider Sophia has filed to go public following some $250m in venture funding.

Mitsui and Nan Fung could exit the rare disease drug developer, which is set to float on the Nasdaq Global Select Market having set a $100m placeholder target.

UC Berkeley’s cell therapy developer has filed for an initial public offering.

Ant Group is set to score an exit when the financial technology platform operator lists in Korea next month in an IPO sized at up to $1.5bn.

The BMW, Dell and Robert Bosch-backed manufacturing services platform has added just over $44m to its initial public offering, its shares having risen 58%.

AbbVie, Novartis, Corteva and Heritage Medical Systems will have an opportunity to exit the cell therapy developer through an initial public offering.

The China-based ride hailing service company debuted in an upsized $4.44bn IPO, giving potential exits to several corporate backers that are among some of its largest external shareholders.

Alphabet and Roc Nation are in line for exits as the online trading platform operator prepares for a flotation potentially valuing it at $40bn.

NTT Docomo, Capital One and Phoenix Insurance could exit the fraud detection software provider, which has announced its intention to float on the New York Stock Exchange.